A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
Tiziana Life Sciences (TLSA) announced the publication of a landmark study in Nature Neuroscience demonstrating that nasal administration of ...
Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results